Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1192/bjp.137.3.303a | DOI Listing |
Am J Psychiatry
November 2024
Division on Substance Use Disorders, New York State Psychiatric Institute, New York; Department of Psychiatry, Columbia University Irving Medical Center, New York.
Substance use disorder (SUD) is common in psychiatric patients and has a negative impact on health and well-being. However, SUD often goes untreated, and there is a need for psychiatrists, of all specialties, to address this pervasive clinical problem. In this review, the authors' goal is to provide a resource that describes treatments for SUD, using neuroscience as a framework.
View Article and Find Full Text PDFPsychiatr Danub
September 2024
BipoSuisse - Psychiatrische Praxis, Vereinsweg 11, CH 3012 Berne, Switzerland,
Ned Tijdschr Geneeskd
November 2023
Isala, Zwolle: Afd. Apotheek.
Background: Since 2006 chocolate containing psilocin is circulating in The Netherlands. Psilocin is a psychoactive substance derived from psychedelic mushrooms and known to be hard drugs. Consuming psilocin can cause symptoms such as hallucinations, fear and panic attacks and sympathomimetic effects.
View Article and Find Full Text PDFEur Neuropsychopharmacol
September 2023
Psychedelic Research Centre, National Institute of Mental Health, Topolová 748, Klecany, 250 67, Czech Republic; 3rd Faculty of Medicine, Charles University, Ruská 87, Prague 10, 100 00, Czech Republic. Electronic address:
Psilocybin is investigated as a fast-acting antidepressant used in conjunction with psychotherapy. Intact cognitive functions, including memory, are one of the basic conditions of effective psychedelic-assisted therapy. While cognitive and memory processing is attenuated on various domains during psilocybin intoxication, the effect of psilocybin on the consolidation of memories learned outside of acute intoxication is not known.
View Article and Find Full Text PDFFront Pharmacol
March 2023
Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia.
-2-methoxy-benzylated ("NBOMe") analogues of phenethylamine are a group of new psychoactive substances (NPS) with reported strong psychedelic effects in sub-milligram doses linked to a number of severe intoxications, including fatal ones. In our present work, we provide a detailed investigation of pharmacokinetics and acute behavioural effects of 2C-B-Fly-NBOMe (2-(8-bromo-2,3,6,7-tetrahydrobenzo [1,2-b:4,5-b']difuran-4-yl)-[(2-methoxybenzyl]ethan-1-amine), an analogue of popular psychedelic entactogen 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). All experiments were conducted on adult male Wistar rats.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!